Chitosan is a deacetylated chitin that may be extracted from the hard outer-skeleton or shells of shrimp, crabs, and lobsters, as well as mushrooms and yeasts. It is largely used as a component of pharmaceuticals to treat renal failure, obesity, anaemia, high cholesterol, hyperphosphatemia, sleeplessness, and Crohn's disease, among other disorders. Chitosan is used in the pharmaceutical industry to create edible films, as a filler in tablets, as a carrier in controlled-release medications, and to increase the dissolvability of some medicinal salts. Chitosan is widely utilised as a natural antimicrobial agent in the cosmetics, agriculture, and food sectors due to its antibacterial and antifungal qualities.
The Chitosan market is expected to rise due to rising product demand from the cosmetics sector and the expanding breadth of product use in waste-water treatment. Furthermore, the government of Mexico has eliminated restrictive rules that limited the installation of new production units, resulting in the development of new and large-scale pharmaceutical manufacturing facilities in the region.
The industrial grade segment accounted for the biggest revenue share in the worldwide market among the grade segments. Chitosan is non-toxic, making it ideal for industrial applications including water filtration and other water treatment procedures. In the worldwide market, the food grade sector is predicted to account for a large revenue share.
Furthermore, the white mushrooms category is expected to grow at the fastest rate during the projection period. Mushrooms are one of the most widely consumed foods, and their waste is employed as a source of chitosan in the food and beverage industry. Read more @ https://cmiaspireblog.blogspot.com/2021/12/chitosan-market-by-source-and-by.html
Source Link:
https://www.coherentmarketinsights.com/infographics/chitosan-market/293
